Menu
Enrolling by invitation NCT05544721

A Study of Paravertebral Block in Thoracic Outlet Syndrome

Phase IV Interventional Thoracic Outlet Syndrome

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Ropivacaine.
Who it may be relevant to
Registry conditions: Thoracic Outlet Syndrome. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Pre-Operative and Post-Operative Paravertebral Block on Patients With Thoracic Outlet Syndrome.

Overview

This research is being done to evaluate the effects of receiving only a paravertebral block prior to first rib resection procedure versus receiving the block both pre and post procedure.

Interventions

  • Drug Ropivacaine
    0.5% 3-4 mL per level, with levels T1 and T2 will be used as the block injectate

Primary outcome measures

  • Change in pain level [Time frame: Time of discharge (approximately 1 day), day 1 post-op, day 3 post-op, day 7 post-op, and day 14 post-op]
Secondary outcome measures (2)
  • Change in quality of life [Time frame: Time of discharge (approximately 1 day), day 1 post-op, day 3 post-op, day 7 post-op, and day 14 post-op]
  • Length of stay [Time frame: Approximately 1 day]

Eligibility criteria

Inclusion criteria

\- All Thoracic Outlet Syndrome patients scheduled for first rib resection surgery.

Exclusion criteria

  • Patients who are pregnant.
  • Patients with prior first rib resection on side of presentation.
  • Patients with complex regional pain syndrome (CRPS).
  • Patients with brachial plexus disorder.
  • Patients with cervical rib.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Supportive care

Study locations

United States · 1 center
  • Mayo Clinic in Florida — Jacksonville

Identifiers

NCT: NCT05544721 · 22-006685

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗